GlassScriptPhysician profile
Abbas Al-Qamari
NPI 1003062175
$40,480.23
in general payments reported to CMS, 2019-2025
6 companies · $21K in 2025
The $21K reported for 2025 was more than what 98% of Critical Care Medicine (Anesthesiology) providers received nationally (typical 2025 total: $97.90).
See the full distribution for Critical Care Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.56 · 2023: $16K · 2024: $4,200 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Travel and Lodging: $3,157 · Honoraria: $1,200 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $970 · Food and Beverage: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,957.41 |
| Travel and Lodging | $3,156.54 |
| Honoraria | $1,200.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $970.00 |
| Food and Beverage | $170.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Potrero Medical, INC. | $25,742.41 | 2023-2025 | |
| Ge Healthcare | $11,457.03 | 2023-2025 | |
| Instrumentation Laboratory Company | $1,200.00 | 2024 | |
| Masimo Corporation | $1,084.59 | 2023 | Patient Safetynet System, Sedline, Set and Rainbow Set |
| Medline Industries LP | $970.64 | 2023 | |
| La Jolla Pharmaceutical Company | $25.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abbas Al-Qamari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.